Page 8 - Clinical Laboratory Automation How To Achieve An Automated Utopia For Your Lab Selectscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical laboratory automation how to achieve an automated utopia for your lab selectscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Laboratory Automation How To Achieve An Automated Utopia For Your Lab Selectscience Today - Breaking & Trending Today

Glycomimetics wilts on missed acute myeloid leukemia phase III

Top-line data from Glycomimetics Inc.’s pivotal phase III study of uproleselan in 388 patients with relapsed/refractory acute myeloid leukemia missed its primary endpoint. The data crippled the stock, which closed at the low point of its 10-year existence. ....

Glycomimetics Inc , Glycomimetics Inc , Acute Myeloid Leukemia , Fast Track Designation , Breakthrough Therapy , Small Molecule ,

Lyra sinks as rhinosinusitis drug-device misses in phase III

Less than a week ago, executives at Lyra Therapeutics Inc. were looking ahead to “imminent” data from its first phase III study in chronic rhinosinusitis (CRS), testing drug-device candidate LYR-210, a drug-device candidate largely expected to fill a much-needed gap in CRS treatment. On Monday, May 6, they were announcing plans to preserve cash in the wake of the failed Enlighten 1 study, which raised doubts as to the feasibility of the company’s CRS programs, which also include the similarly designed candidate LYR-220. ....

Lyra Therapeutics Inc , Lyra Therapeutics , Lyr 220 , Lyra Therapeutics Inc , Bioworld Medtech , Combination Drug Device , Lyr 210 , Mometasone Furoate , Chronic Rhinosinusitis ,